Program evaluations can play an important role in formulating goals, objectives, and implementation strategies for a variety of planning activities throughout the Department of Health and Human Services (HHS). Program evaluations also tell us whether our efforts are successful. While there are still gaps in what we know, we now are beginning to as
In some cases, achieving our strategic goals and objectives may be impeded by factors that are beyond the control of the Department of Health and Human Services (HHS). For example, national or local economic conditions can influence whether we are successful in helping families on welfare become economically independent. In some cases, there may b
Many programs within the Department have goals, objectives, and target populations that appear similar. Likewise, many Department programs appear to duplicate or overlap programs in other Federal agencies. Many state, local, and private sector programs also have goals, objectives, and target populations in common with Department programs. Because
HHS Strategic Goals and Objectives - FY 2001 . Objective 6.4 - Accelerate Private-Sector Development of New Drugs, Biologic Therapies, and Medical Technology
How We Will Accomplish Our Objective We will accelerate development by: applying state-of-the-art science knowledge to ensure timely review of important new medical products. streamlining the review processes for approval of new drugs, therapies, and technology.
Pew Research Center (2006). More Americans Discussing -- and Planning -- End-of-Life Treatment . Available at http://people-press.org/reports/display.php3?PageID=1029.
Advance Care Planning and Public Engagement. A. Social Dimensions of the EOL Decision Making Process
Reducing death to a clinical event inappropriately diminishes the personal and social dimensions of dying. Although dying occurs more often than not within a clinical setting and is nearly always “attended” by a physician, it nevertheless contains a human existential element. Humans are social beings -- all of us live and die within the contex
Advance Care Planning and Public Engagement. II. Managing Our Miracles and the Emergence of a Social Consensus
The management of the effective use of penicillin in the early 1940s is often described as one of the most important moments in the history of medicine. 14 This turning point in medical treatment provided physicians the capacity to intervene routinely in the “natural process” by eradicating lethal infection. The effect was to elevate the “
Myra J. Christopher and John G. Carney Center for Practical Bioethics
Health Care in Transition: Technology Assessment in the Private Sector Prepared by: Richard Rettig of the RAND Corporation Office of the Assistant Secretary of Planning and Evaluation Agency for Health Care Policy and Research. July, 1996.
Element Description/Notes State and Lead Agency Kansas Department of Health and Environment (KDHE)
This report describes how frequently various quality requirement elements appear in managed care organization contracts, as well as some similarities and differences in the quality requirements.
While these finding are not definitive, they offer suggestive information about the factors that may have affected recent Medicare spending trends. As noted below, in many cases, multiple factors may have contributed to trends for individual service categories.
The rate of national health care spending growth per person has been on a downward trajectory in recent years (see Figure 1). This downward trend has been especially significant for the Medicare program since 2009.
Report Citations The studies are listed below in order of their Policy Information Center identification (PIC ID) number. The studies have been conducted by or funded through the Department of Health and Human Services by the specific agency or office sponsor. Reports may be obtained at the URL hotlinks provided, or from the Fed
A study evaluated whether the National Institute of Biomedical Imaging and Bioengineering, Biomedical Technology Resource Center Program, had been achieving its performance goals. The Centers support novel, cutting-edge, multidisciplinary technology research and development, targeting a range of biomedical applications. The Centers generally
This report, Performance Improvement 2010, the 16th annual report in this series, describes the findings from 113 studies completed during the fiscal year ending September 30, 2009. The study summaries and the publicly available database from which they are drawn are to be found at http://aspe.hhs.gov/pic/performance.
Performance Improvement 2008. How Best Measure Success of the Innovative Molecular Analysis Program?
This study examined the feasibility and informed the design of an outcome evaluation for the National Cancer Institute´s Innovative Molecular Analysis Technologies (IMAT) program. IMAT is a trans-NCI program aimed at accelerating technology development efforts to better treat, diagnose, detect, and prevent cancer.
Strategic Goals and Objectives “PREVENTING DISEASE AND ILLNESS” Objective Title GOAL 1: